Navigation Links
The MedZilla Report: April 2009 Employment Outlook for Biotech/Pharma/Health
Date:5/25/2009

Despite announcements of layoffs in the healthcare field, job growth rose slightly, with 17,000 more jobs created in April. Though there was an increase of more than 20 percent from March, job growth overall is off by about 40 percent compared to 2008.

Seattle, WA (Vocus) May 25, 2009 -- With first quarter job growth in healthcare off by about 40 percent from first quarter 2008, job seekers might have expressed concern that a field once thought to be recession-proof was succumbing to economic pressures. However, job growth remained steady through April, with 17,000 new jobs created -- 3,000 more than in March.

As healthcare groups look to save money without cutting patient care standards, they have begun highlighting more alternatives to layoffs, such as unpaid furloughs, salary and 401(k) freezes, and the elimination of executive positions. Unfortunately, this step is rarely enough -- in healthcare, pharmaceuticals, or any other industry -- and more layoffs were announced in April. Many hospital systems said they were planning to terminate some employees as well as freezing open positions. Moreover, one of the biggest -- New York City Health and Hospitals -- said their recent 400-deep layoff action was not enough, owing to an increase in uninsured patients (Wall Street Journal Abstracts, April 13, 2009). "Even as people lose jobs across the board, they still need health care," said Michele Hopps, director of marketing for MedZilla.com, the internet's leading source for healthcare, pharmaceutical, and biotechnology employment. "Hospitals can't in good conscience turn away people who need help, but if they're not getting reimbursed, they lose money and have to make it up in other ways. Sometimes that means layoffs." One interesting piece of mixed news on healthcare layoffs came from the Associated Press (April 18, 2009) -- a hospital in Paducah, Ky., cited a weake
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
2. The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
3. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
4. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
5. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
6. Medarex to Host Business and Financial Update Conference Call on Thursday, April 30, 2009
7. Shire plc: Results of the Annual General Meeting Held on April 28, 2009
8. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
9. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
10. InterMune to Release First Quarter Financial Results on April 30
11. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: April 2009 Employment Outlook for Biotech/Pharma/Health
(Date:12/17/2014)... Indianapolis, IN (PRWEB) December 17, 2014 ... for Laboratory Excellence following its most recent COLA ... Accreditation by COLA, a national healthcare accreditation organization. ... rigid standards of quality in day-to-day operations, demonstrate ... and pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... the next step in its expanded strategy to rebuild ... the naming of current Chief Operating Officer, Valerie ... current Chairman of the Board and CEO James ... changes are effective January 1, 2015. "Jim ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , ... BCLI ), a leading developer of adult ... wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a ... Office of the Chief Scientist (OCS).  This ... receipt of grant support from the Office of the ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... SAN FRANCISCO, Calif., March 5 Poniard Pharmaceuticals, ... company focused on innovative oncology therapies, today announced ... discuss the Company,s fourth quarter and year-end financial ... development activities for picoplatin, the Company,s lead product ...
... Proteon Therapeutics, Inc., announced today that it has successfully ... by MPM Capital on behalf of the MPM Bio ... the initiation of a Phase 1/2 human clinical study ... stage renal disease undergoing surgery for arteriovenous fistula (AVF) ...
... - Proceeds to Facilitate Clinical Development of ... a pioneer in the development of innovative conjugated,vaccines, today ... million, EUR17 million) Series B financing. The round was ... Ventures and,Sofinnova Partners, expressed their commitment to the future ...
Cached Biology Technology:Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12 2Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company 2GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... In a multifaceted study involving the Kuna Indians ... pinpointed a chemical compound that is, in part, ... and some chocolate products. , The researchers, who ... Heinrich-Heine University of Duesseldorf, Germany; and Harvard Medical ...
... using a toothbrush, the Norwegians found one using a drill. The ... Sea, at an entire 2256 metres below the seabed. It had ... the North Sea wasn't a sea at all, but an enormous ... of the old dinosaur now see the light of day again, ...
... against not only multi drug-resistant forms of the disease but ... stage of infection as well. Researchers report their results ... class of which this compound is the lead has a ... used to treat tuberculosis. We have identified no cross ...
Cached Biology News:Heart-healthy compound in chocolate identified 2Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2
...
...
with GlutaMAXIL-glutamine...
... GOAT ANTI-MOUSE IgG+IgA+IgM (H+L) ... with highly purified horseradish ... antibody has been absorbed ... fetal bovine, horse, goat, ...
Biology Products: